195 related articles for article (PubMed ID: 35878189)
1. Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update.
Hyodo M; Hirose K; Nagao A; Nakahira M; Kobayashi T
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878189
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.
Hyodo M; Nagao A; Asano K; Sakaguchi M; Mizoguchi K; Omori K; Tada Y; Hatakeyama H; Oridate N; Naito K; Iwata Y; Shinomiya H; Hara H; Sanuki T; Yumoto E
Eur J Neurol; 2021 May; 28(5):1548-1556. PubMed ID: 33393175
[TBL] [Abstract][Full Text] [Related]
3. Sulcus vocalis in spasmodic dysphonia-A retrospective study.
Nerurkar NK; Agrawal D; Joshi D
Am J Otolaryngol; 2021; 42(3):102940. PubMed ID: 33545449
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.
Hyodo M; Asano K; Nagao A; Hirose K; Nakahira M; Yanagida S; Nishizawa N
Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941678
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia.
Sanuki T; Takemoto N
Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482
[TBL] [Abstract][Full Text] [Related]
6. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
van Esch BF; Wegner I; Stegeman I; Grolman W
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
[TBL] [Abstract][Full Text] [Related]
7. [Spasmodic Dysphonia].
Tokashiki R
Brain Nerve; 2023 Jan; 75(1):15-22. PubMed ID: 36574969
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
Kosztyła-Hojna B; Berger G; Zdrojkowski M
Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
[TBL] [Abstract][Full Text] [Related]
9. Neurectomy and Myomectomy for Treatment of Spasmodic Dysphonia.
Ryan W; Alnouri G; Sataloff RT
J Voice; 2024 Jan; 38(1):239-242. PubMed ID: 35738960
[TBL] [Abstract][Full Text] [Related]
10. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective.
Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM
Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect?
Oktay Arslan B; Demirhan E; Uçar Hoşgör ZZ
J Voice; 2022 Jan; 36(1):119-122. PubMed ID: 32482493
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.
Patel PN; Kabagambe EK; Starkweather JC; Keller M; Gamsarian V; Lee J; Kulkarni V; Garrett CG; Francis DO
JAMA Otolaryngol Head Neck Surg; 2018 Apr; 144(4):293-299. PubMed ID: 29423509
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and adverse effects of unilateral or bilateral botulinum toxin injections for adductor spasmodic dysphonia: a systematic review and meta-analysis.
Liu Y; Chen F; Liang F; Wang C; Chen D; Zhou J; Zhang L; Xiao X; He R; Tang L; Tian L; Zhou L
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1357-1369. PubMed ID: 38095707
[TBL] [Abstract][Full Text] [Related]
14. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
Mendelsohn AH; Berke GS
Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort.
French G; Bosch JD; Randall DR
J Otolaryngol Head Neck Surg; 2020 Jan; 49(1):4. PubMed ID: 31937363
[TBL] [Abstract][Full Text] [Related]
16. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia.
Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA
Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480
[TBL] [Abstract][Full Text] [Related]
17. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
Cha W; Jang JY; Wang SG; Kang JH; Jo MG
J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
[TBL] [Abstract][Full Text] [Related]
18. Coagulation of posterior cricoarytenoid muscles for abduction spasmodic dysphonia.
Samaha M; Remacle M
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):839-841. PubMed ID: 33392763
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period.
Namin AW; Christopher KM; Eisenbeis JF
J Voice; 2017 Jan; 31(1):107-110. PubMed ID: 27005439
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]